Page last updated: 2024-12-10

zeta carotene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

zeta Carotene: A carotenoid produced in most carotenogenic organisms. It is one of several sequentially synthesized molecules that are precursors to BETA CAROTENE. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6440490
CHEBI ID48716
MeSH IDM0003537

Synonyms (18)

Synonym
9,9'-di-cis-zeta-carotene
9,9'-dicis-zeta-carotene
zeta carotene
(6e,10z,12e,14e,16e,18e,20e,22z,26e)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,20,22,26,30-undecaene
CHEBI:48716
(9-cis,9'-cis)-7,7',8,8'-tetrahydro-psi,psi-carotene
9-cis,9'-cis-7,8,7',8'-tetrahydro-psi,psi-carotene
72746-33-9
LMPR01070295
341qz5n3e6 ,
psi,psi-carotene, 7,7',8,8'-tetrahydro-, (9-cis,9'-cis)-
unii-341qz5n3e6
.zeta.-carotene
.psi.,.psi.-carotene, 7,7',8,8'-tetrahydro-, (9-cis,9'-cis)-
(9-cis,9'-cis)-7,7',8,8'-tetrahydro-.psi.,.psi.-carotene
Q27121351
zeta -carotene
DTXSID501030374

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Our objective was to compare the bioavailability of lycopene from tangerine to red tomato juice, and elucidate physical deposition forms of these isomers in tomatoes by light and electron microscopy."( Enhanced bioavailability of lycopene when consumed as cis-isomers from tangerine compared to red tomato juice, a randomized, cross-over clinical trial.
Clinton, SK; Cooperstone, JL; Francis, DM; Haufe, TC; King, SA; Lesinski, GB; Ralston, RA; Riedl, KM; Schwartz, SJ; Schweiggert, RM; Timmers, CD, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
zeta-carotene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (5)

PathwayProteinsCompounds
trans-lycopene biosynthesis II (oxygenic phototrophs and green sulfur bacteria)713
superpathway of carotenoid biosynthesis in plants431
superpathway of carotenoid biosynthesis in plants2432
trans-lycopene biosynthesis II (oxygenic phototrophs and green sulfur bacteria)814
trans-lycopene biosynthesis II (plants)610
superpathway of carotenoid biosynthesis029
Lycopene biosynthesis010

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (4.17)18.7374
1990's0 (0.00)18.2507
2000's5 (20.83)29.6817
2010's8 (33.33)24.3611
2020's10 (41.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.17%)5.53%
Reviews1 (4.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]